Found: 30
Select item for more details and to access through your institution.
Prime boost vaccines power up in people.
- Published in:
- Nature Medicine, 2003, v. 9, n. 6, p. 642, doi. 10.1038/nm0603-642
- By:
- Publication type:
- Article
Shots in the Dark: The Wayward Search for an AIDS Vaccine.
- Published in:
- 2001
- By:
- Publication type:
- Book Review
Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles.
- Published in:
- Nature Medicine, 2000, v. 6, n. 7, p. 776, doi. 10.1038/77506
- By:
- Publication type:
- Article
Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations.
- Published in:
- Nature Medicine, 1999, v. 5, n. 5, p. 526, doi. 10.1038/8406
- By:
- Publication type:
- Article
The Induction of Mucosal Immunity in the Female Genital Tract Using Gene-Gun Technology Part 1: Antigen Expression.
- Published in:
- Annals of the New York Academy of Sciences, 1995, v. 772, n. 1, p. 265, doi. 10.1111/j.1749-6632.1995.tb44755.x
- By:
- Publication type:
- Article
Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
- Published in:
- International Immunology, 2005, v. 17, n. 5, p. 637, doi. 10.1093/intimm/dxh245
- By:
- Publication type:
- Article
Viral attenuation by design.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 9, p. 1000, doi. 10.1038/nbt0908-1000
- By:
- Publication type:
- Article
Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases.
- Published in:
- Nature Biotechnology, 2001, v. 19, n. 6, p. 543, doi. 10.1038/89289
- By:
- Publication type:
- Article
Protective immunity from a germinal center sanctuary.
- Published in:
- Nature Medicine, 2012, v. 18, n. 11, p. 1614, doi. 10.1038/nm.2986
- By:
- Publication type:
- Article
T cell vaccines for microbial infections.
- Published in:
- Nature Medicine, 2005, v. 11, p. 25, doi. 10.1038/nm1212
- By:
- Publication type:
- Article
Heterologous Neutralizing Antibody Induction in a Simian-Human Immunodeficiency Virus Primate Model: Lack of Original Antigenic Sin.
- Published in:
- Journal of Infectious Diseases, 2001, v. 184, n. 12, p. 1603, doi. 10.1086/324582
- By:
- Publication type:
- Article
DNA Immunization for Influenza Virus: Studies Using Hemagglutinin- and Nucleoprotein-Expressing DNAs.
- Published in:
- Journal of Infectious Diseases, 1997, v. 176, n. Supplement_1, p. S50
- By:
- Publication type:
- Article
Protection Against Rotavirus Infections By DNA Vaccination.
- Published in:
- Journal of Infectious Diseases, 1996, v. 174, n. Supplement_1, p. S93
- By:
- Publication type:
- Article
Basic Mechanisms of DNA-Raised Antibody Responses to Intramuscular and Gene Gun Immunizations.
- Published in:
- DNA & Cell Biology, 2000, v. 19, n. 3, p. 157, doi. 10.1089/104454900314546
- By:
- Publication type:
- Article
Effect of CpG Methylation on Isotype and Magnitude of Antibody Responses to Influenza Hemagglutinin-Expressing Plasmid.
- Published in:
- DNA & Cell Biology, 1999, v. 18, n. 9, p. 663, doi. 10.1089/104454999314944
- By:
- Publication type:
- Article
Prevention of Infection by a Granulocyte-Macrophage Colony-Stimulating Factor Co-Expressing DNA/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 1, p. 164, doi. 10.1093/infdis/jir199
- By:
- Publication type:
- Article
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 5, p. 610
- By:
- Publication type:
- Article
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. Suppl 2, p. 610
- By:
- Publication type:
- Article
Phase 1 Clinical Trials of the National Institutes of Health Vaccine Research Center HIV/AIDS Candidate Vaccines.
- Published in:
- Journal of Infectious Diseases, 2006, v. 194, n. 12, p. 1625, doi. 10.1086/509263
- By:
- Publication type:
- Article
VARIATION IN AVIAN RETROVIRUS GENOMES*.
- Published in:
- Annals of the New York Academy of Sciences, 1980, v. 354, n. 1, p. 410, doi. 10.1111/j.1749-6632.1980.tb27982.x
- By:
- Publication type:
- Article
VACCINES: NEW HOPE FOR AN AIDS VACCINE.
- Published in:
- Nature Reviews Immunology, 2002, v. 2, n. 4, p. 239, doi. 10.1038/nri776
- By:
- Publication type:
- Article
T cells versus HIV-1: fighting exhaustion as well as escape.
- Published in:
- Nature Immunology, 2003, v. 4, n. 1, p. 12, doi. 10.1038/ni0103-12
- By:
- Publication type:
- Article
C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge.
- Published in:
- Nature Immunology, 2000, v. 1, n. 2, p. 127, doi. 10.1038/77802
- By:
- Publication type:
- Article
Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm).
- Published in:
- Journal of Medical Primatology, 1999, v. 28, n. 3, p. 97, doi. 10.1111/j.1600-0684.1999.tb00257.x
- By:
- Publication type:
- Article
HIV/AIDS Vaccines: 2018.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 6, p. 1062, doi. 10.1002/cpt.1208
- By:
- Publication type:
- Article
Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-69007-w
- By:
- Publication type:
- Article
DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0163164
- By:
- Publication type:
- Article
Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00305-8
- By:
- Publication type:
- Article
HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0177863
- By:
- Publication type:
- Article
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0179597
- By:
- Publication type:
- Article